JNJ vs VRTV: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Veritiv Corporation β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson Β· Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction
Grade D
QuantHub Verdict
JNJ has more upside to fair value
(+5.7%).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
JNJ |
VRTV |
| Current Price |
$270.68 |
$169.99 |
| Fair Value Estimate |
$286.05 |
$93.49 |
| Upside to Fair Value |
+5.7%
|
-45.0%
|
| Market Cap |
$652.3B |
$2.3B |
| Forward P/E |
β
|
β
|
| EV / EBITDA |
20.2x
|
5.4x
|
| Price / Sales |
6.7x
|
0.4x
|
| Price / FCF |
35.3x
|
10.4x
|
| Revenue Growth YoY |
+6.6%
|
-19.0%
|
| Gross Margin |
67.9%
|
22.7%
|
| Operating Margin |
26.8%
|
5.9%
|
| Return on Equity |
25.7%
|
48.6%
|
| Dividend Yield |
1.95% |
1.48% |
| FCF Yield |
2.83%
|
9.57%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:β¦
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year inβ¦
Accumulation Zones
| Metric |
JNJ |
VRTV |
| Zone Low |
$214.54 |
$70.12 |
| Zone High |
$243.14 |
$79.47 |
| In Buy Zone? |
No
|
No
|